AGAbha Goyal

Abha Goyal

*This is an algorithmically generated author record based on publicly available information.

Abha Goyal has a total of 90 co-authors. Here are the top co-authors by number of shared publications:

  • Momin T. Siddiqui

    Department of Pathology and Laboratory Medicine, New York-Presbyterian Hospital-Weill Cornell Medicine, New York, New York

    5 shared publications
  • Jonas J. Heymann

    Department of Pathology and Laboratory Medicine, New York-Presbyterian Hospital-Weill Cornell Medicine, New York, New York

    4 shared publications
  • Susan A. Alperstein

    Division of Cytopathology New York‐Presbyterian Hospital–Weill Cornell Medical College New York New York USA

    4 shared publications
  • Rema Rao

    Department of Pathology Montefiore Medical Center Bronx New York USA

    3 shared publications
  • Thomas L. Dilcher

    Department of Pathology and Laboratory Medicine, Weill Cornell Medicine-New York Presbyterian Hospital, New York, New York

    3 shared publications
  • Ami Patel

    Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York

    2 shared publications

Latest Publications

  • Interdisciplinary and inter-personnel issues during rapid on-site evaluation: an analysis of 2025 American Society of Cytopathology survey results

    by Abha Goyal, Susan A. Alperstein, Valentina Robila, Jeffrey K. Mito, Vanda Torous, Jennifer Kernodle, Kristen E. Natale, Jinous Saremian, Aziza Nassar

  • Comprehensive assessment of cytologist workplace needs and evolving professional landscape

    by Vanda F. Torous, Nathalie Andon, Abha Goyal, Jennifer Kernodle-Zimmer, Jeffrey K. Mito, Valentina Robila, Mauro Saieg, Jinous Saremian, Aziza Nassar


  • Unsatisfactory Pap Test Results: A Critical Patient Management Problem Pre‐Analytically Addressed by the Cytopathology Laboratory

    by Mohamad M. Gafeer, Susan Alperstein, Robert Appleby, Jose‐Scarpa Carniello, Jonas J. Heymann, Abha Goyal, Momin T. Siddiqui

    Background: The unsatisfactory rate of Pap tests (PT) is an important quality assurance (QA) metric for a cytopathology laboratory. At our institution, an unsatisfactory PT slide is followed by a second ThinPrep (TP) slide. The aim of this study is to evaluate this QA practice.Methods: Our laboratory processes an unsatisfactory TP PT with a follow‐up second TP slide with or without glacial acetic acid. The correlation between the unsatisfactory rate and the second slide rate test was examined.Results: A total of 2739 cases with a second TP slide were prepared for an unsatisfactory initial TP PT. After second slide preparation, 780 cases (28%) remained unsatisfactory. Using Spearman's rank correlation test, there was a notable negative correlation between the unsatisfactory rate and the second slide rate (rho = −0.42). Of those PTs recategorized as satisfactory TP, 1742 were negative for intraepithelial lesion or malignancy (NILM) (89%), 135 as atypical squamous cells of undetermined significance (ASC‐US) (7%), 37 as low‐grade squamous intraepithelial lesion (LSIL) (1.9%), 11 as atypical squamous cells cannot exclude high‐grade squamous intraepithelial lesion (ASC‐H) (0.6%), 8 as high‐grade squamous intraepithelial lesion (HSIL) (0.4%), and 20 as atypical glandular cells (AGC) (1%). The final Bethesda categorization for all cases and the human papilloma virus (HPV) data was tabulated.Conclusions: A second slide preparation significantly reduced the unsatisfactory rate of the PT. This also had a significant impact by detecting clinically significant lesions. HPV testing can also be performed on slides reclassified from unsatisfactory to ASC‐US or higher.


  • Open Access

    COMPARISON OF NEW MR APPROACHES FOR ACCELERATED KNEE IMAGING

    by A. Goyal, M. Petterson, R. Van der Heijden, K. Stevens, M. Yoon, J. MacKay, M. Fung, F. Kogan

  • Open Access

    Navigating Practice Issues Related to the Unsatisfactory Cervicovaginal Papanicolaou Test: Survey Results of Laboratories Participating in the 2020 College of American Pathologists PAP Education Program

    by Abha Goyal, Christine N. Booth, Rhona J. Souers, Sana O. Tabbara, Janie Roberson, Michael R. Henry, Kaitlin E. Sundling, Kelly Goodrich, Lananh Nguyen

    Context.—: Unsatisfactory Papanicolaou (Pap) tests pose a unique set of challenges to the laboratory with regard to their processing, review, reporting, and performance of human papillomavirus (HPV) testing. There are no standardized guidelines for the review process and handling of unsatisfactory Pap tests. Objective.—: To assess the current practice patterns regarding various aspects of the unsatisfactory Pap test, from processing to reporting, across laboratories worldwide. Design.—: A supplemental questionnaire was mailed to laboratories participating in the 2020 College of American Pathologists (CAP) Gynecologic Cytopathology (PAP Education) Program, requesting data regarding the unsatisfactory Pap test. Results.—: Of 1520 participating laboratories, 619 (40.7%) responded, and the responses of 577 laboratories were included for further analysis. Only 64.6% (373 of 577) laboratories used the unsatisfactory Pap test criteria as specified by the 2014 Bethesda System. About three-quarters of the respondents (433 of 576; 75.2%) routinely rescreened unsatisfactory Pap tests. Routine repreparation of such Pap tests was performed by 54.9% (316 of 576) of laboratories, and 52.0% (293 of 563) used glacial acetic acid for repreparing excessively bloody specimens. HPV test results were reported for unsatisfactory Pap tests, always or sometimes, by 62.4% (353 of 566) of respondents. Conclusions.—: This CAP survey reveals important information regarding the practice patterns pertaining to several aspects of the unsatisfactory Pap test. It also provides valuable insight into the quality assurance measures that can be implemented for such tests. Future studies can further aid in the standardization of all components of the handling of unsatisfactory Pap tests for overall quality improvement.


  • Diagnostic implication of extracellular mucin in pancreatic/biliary brushing and stent cytology

    by Jesse Suben, Abha Goyal, Rema Rao, Simon Sung

    Background: Pancreatic and/or biliary (PB) brushing is commonly used to rule out malignant strictures. Many studies have attempted to characterize cytomorphologic characteristics of brushing and stent cytology. However, scant literature exists on the diagnostic implication (DI) of thick extracellular mucin (ECM) indicative of neoplasm in these samples. This study was aimed at reviewing the DI of thick ECM in PB brushing and stent cytology. Methods: A retrospective search of consecutive cytologic samples of PB brushings/stents with corresponding surgical pathology or relevant clinical information over a 1‐year period was performed. Blinded review of the slides was performed by two cytopathologists. The slides were assessed for the presence, quantity, and quality of ECM. The results were analyzed for statistical significance with the Fisher exact and χ 2 tests. Results: One hundred ten cases were identified from 63 patients. Twenty‐two cases (20%) were PB brushings only without a prior stent. The remaining 88 cases (80%) had a preexisting stent for symptomatic obstruction. Fourteen of 22 cases (63%) without prior stents and 67 of 88 poststented cases (76%) were nonneoplastic (NN) upon follow‐up. ECM was present more frequently in neoplastic cases than in NN cases ( p = .03). Among NN cases ( n = 87), poststented samples showed more evidence of ECM than prestented samples (15% vs. 45%, p = .045). Identical thick ECM was observed in NN poststent and main‐duct intraductal papillary neoplasm samples. Conclusions: Although ECM was frequently seen in neoplastic cases, NN cases showed increased evidence of thick ECM among poststented samples. Thick ECM may be common in stent cytology, regardless of the underlying biologic process.


  • Diagnostic features of low‐ and high‐grade mucinous neoplasms in pancreatic cyst FNA cytology

    by Carlie Sigel, Xiao‐Jun Wei, Narasimhan Agaram, Keith Sigel, Roshan Raza, Rebecca Andrade, Rema Rao, Pari Shah, Kevin Soares, Abha Goyal

    Background: Pancreatic cyst cytology evaluates for neoplastic mucin and epithelial grade. This study describes cytological features of low‐ and high‐grade mucinous neoplasms (MNs) using gastrointestinal contaminants for comparison.Methods: Histologically confirmed pancreatic cystic neoplasms were reviewed by a panel of cytopathologists to identify which, among 26 selected cytologic features, correlate significantly with low‐ and high‐grade MN. A test for greater than or equal to four of eight high‐grade features (three‐dimensional architecture, high nuclear:cytoplasmic ratio, moderate nuclear membrane abnormalities, loss of nuclear polarity, hyperchromasia, >4:1 nuclear size variation in one cluster, karyorrhexis, and necrosis) was assessed for identifying a high‐grade neoplasms. Additional characteristics of the cohort such as cyst fluid carcinoembryonic antigen results, molecular testing, Papanicolaou Society of Cytopathology classification, and select high‐risk clinical features are described.Results: Endoscopic ultrasound fine‐needle aspirations from 134 MN and 17 serous cystadenomas containing gastrointestinal contaminants were included. The MN consisted of 112 (84%) intraductal papillary MNs (low‐grade = 69, 62%; high‐grade = 24, 21%; and invasive = 19, 17%) and mucinous cystic neoplasms (low‐grade = 20, 90%; high‐grade = 2, 10%). Half had greater than five clusters of epithelium for analysis. Compared with gastrointestinal contaminants, mucin from MN was thick and colloid‐like (40% vs. 6%, p < .01), covered >20% of the smear area (32% vs. none, p < .01), and contained histiocytes (46% vs. 18%, p = .04). Greater than or equal to four of eight select high‐grade features was present in 36% of high‐grade MN with sensitivity 37% and 98% specificity.Conclusion: Colloid‐like features, >20% of smear, and histiocytes correlated with MN. Testing for greater than or equal to four high‐grade features had low sensitivity and high specificity for high‐grade MN.


  • Evaluating the role of Z‐stack to improve the morphologic evaluation of urine cytology whole slide images for high‐grade urothelial carcinoma: Results and review of a pilot study

    by David Kim, Robert Burkhardt, Susan A. Alperstein, Hamza N. Gokozan, Abha Goyal, Jonas J. Heymann, Ami Patel, Momin T. Siddiqui

    BACKGROUND: Whole slide imaging (WSI) adoption has been slower in cytopathology due, in part, to challenges in multifocal plane scanning on 3‐dimensional cell clusters. ThinPrep and other liquid‐based preparations may alleviate the issue by reducing clusters in a concentrated area. This study investigates the use of Z‐stacked images for diagnostic assessment and the experience of evaluating urine ThinPrep WSI. METHODS: Thirty ThinPrep urine cases of high‐grade urothelial carcinoma (n = 22) and cases of negative for high‐grade urothelial carcinoma (n = 8) were included. Slides were scanned at 40× magnification without Z‐stack and with Z‐stack at 3 layers, 1 μm each. Six cytopathologists and 1 cytotechnologist evaluated the cases in 2 rounds with a 2‐week wash‐out period in a blinded manner. A Cohen’s Kappa (CK) calculated concordance rates. A survey after each round evaluated participant experience. RESULTS: CK with the original report ranged from 0.606 to 1.0 ( P < .05) without Z‐stack and 0.533 to 1.0 ( P < .05) with Z‐stack both indicating substantial‐to‐perfect concordance. For both rounds, interobserver CK was moderate‐to‐perfect (0.417‐1.0, P < .05). Intraobserver CK was 0.697‐1.0 ( P < 0.05), indicating substantial to perfect concordance. The average scan time and file size for slides without Z‐stack and with Z‐stack are 6.27 minute/0.827 GB and 14.06 minute/2.650 GB, respectively. Surveys demonstrated a range in comfort and use with slightly more favorable opinions for Z‐stacked cases. CONCLUSIONS: Z‐stack images provide minimal diagnostic benefit for urine ThinPrep WSI. In addition, Z‐stacked urine WSI does not justify the prolonged scan times and larger storage needs compared to those without Z‐stack.


  • Combining molecular testing and the Bethesda category III:VI ratio for thyroid fine‐needle aspirates: A quality‐assurance metric for evaluating diagnostic performance in a cytopathology laboratory

    by Hamza N. Gokozan, Thomas L. Dilcher, Susan A. Alperstein, Yuqing Qiu, Maria Mostyka, Theresa Scognamiglio, James P. Solomon, Wei Song, Hanna Rennert, Shaham Beg, et al.

    Background: Molecular testing (MT) of thyroid fine‐needle aspiration (FNA)‐derived genetic material is commonly used to assess malignancy risk for indeterminate cases. The Bethesda System for Reporting Thyroid Cytopathology (TBS) provides limited guidance for the appropriate use of category III (atypia of undetermined significance [AUS]). The authors combined MT with cytomorphology to monitor AUS diagnoses in a cytopathology laboratory.Methods: Neoplasia‐associated genetic alterations (NGAs) were determined by MT of preoperative FNA biopsies or resected malignancies and were categorized as BRAF V600E mutations, RAS‐like mutations (HRAS, NRAS, or KRAS mutations or non‐V600E BRAF mutations), or other mutations.Results: Among 7382 thyroid FNA biopsies, the AUS rate was 9.3% overall and ranged from 4.3% to 24.2% among 6 cytopathologists (CPs) who evaluated >150 cases. The ratio of specimens falling into TBS category III to specimens falling into category VI (malignant) (the III:VI ratio) was 2.4 overall (range, 1.1‐8.1), and the ratio of specimens falling into TBS categories III and IV (follicular neoplasm or suspicious for follicular neoplasm) combined (III+IV) to specimens falling into category VI (the [III+IV]:VI ratio) was 2.9 overall (range, 1.4‐9.5). MT was performed on 588 cases from 560 patients (79% women) with a median age of 56 years (range, 8‐89 years). BRAF V600E mutation was the most common (76% of cases) in TBS category VI and was rare (3%) in category III. RAS‐like mutations were most common in TBS categories III (13%), IV (25%), and V (suspicious for malignancy) (17.5%). The NGA rate in AUS cases fell between 5% and 20% for 5 of 6 CPs and did not correlate with the III:VI ratio or the (III+IV):VI ratio.Conclusions: Lack of correlation between the NGA rate and easily calculable diagnostic ratios enables the calibration of diagnostic thresholds, even for CPs who have normal metrics. Specifically, calculation of the NGA rate and the III:VI ratio may allow individual CPs to determine whether they are overcalling or undercalling cases that other CPs might otherwise recategorize.